TY - JOUR
T1 - Chronic myelogenous leukemia‐derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a
AU - Kretzschmar, Titus
AU - Jeromin, Andreas
AU - Gietz, Claudia
AU - Bautsch, Wilfried
AU - Klos, Andreas
AU - Köhl, Jörg
AU - Rechkemmer, Gerhard
AU - Bitter‐Suermann, Dieter
PY - 1993/2/1
Y1 - 1993/2/1
N2 - The receptor for the inflammatory peptide C3a has scarcely been examined on human cells. This work demonstrates that human tumor‐derived basophilic granulocytes express C3a receptors, and presents parts of the hitherto unknown C3a‐signal transduction. When incubated with IL‐3, these cells specifically liberated histamine on C3a stimulation. Independent from IL‐3, 240000 ± 100000 receptors per cell with a Kd of 5.6 ± 0.9 nM were determined. (Ca2+)j increased from 120 ± 35 nM to 300 ± 80 nM after a C3a challenge, as measured by digital imaging fluorescence microscopy, and rested at its basal level in the presence of C3a‐desArg, the immediate catabolic product of C3a in vivo. This (Ca2+ )i increase could be completely desensitized homologously by C3a as well as inhibited by up to 75% by pertussis toxin. Thus, tumor‐derived basophils are suitable for cloning of the human C3a receptor.
AB - The receptor for the inflammatory peptide C3a has scarcely been examined on human cells. This work demonstrates that human tumor‐derived basophilic granulocytes express C3a receptors, and presents parts of the hitherto unknown C3a‐signal transduction. When incubated with IL‐3, these cells specifically liberated histamine on C3a stimulation. Independent from IL‐3, 240000 ± 100000 receptors per cell with a Kd of 5.6 ± 0.9 nM were determined. (Ca2+)j increased from 120 ± 35 nM to 300 ± 80 nM after a C3a challenge, as measured by digital imaging fluorescence microscopy, and rested at its basal level in the presence of C3a‐desArg, the immediate catabolic product of C3a in vivo. This (Ca2+ )i increase could be completely desensitized homologously by C3a as well as inhibited by up to 75% by pertussis toxin. Thus, tumor‐derived basophils are suitable for cloning of the human C3a receptor.
UR - http://www.scopus.com/inward/record.url?scp=0027476272&partnerID=8YFLogxK
U2 - 10.1002/eji.1830230239
DO - 10.1002/eji.1830230239
M3 - Journal articles
C2 - 7679650
AN - SCOPUS:0027476272
SN - 0014-2980
VL - 23
SP - 558
EP - 561
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 2
ER -